These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21726614)

  • 1. A priori performance predictions in the pharmaceutical sciences.
    Hancock BC; Morris KR; Wildfong PL
    Int J Pharm; 2011 Oct; 418(2):149-50. PubMed ID: 21726614
    [No Abstract]   [Full Text] [Related]  

  • 2. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 3. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
    [No Abstract]   [Full Text] [Related]  

  • 5. Redesigner drugs.
    Dove A
    Nat Biotechnol; 2004 Aug; 22(8):953-7. PubMed ID: 15286643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADMET--Fifth Annual SMi Conference.
    Comer JE
    IDrugs; 2010 Sep; 13(9):610-4. PubMed ID: 20799141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connecting the dots: role of standardization and technology sharing in biological simulation.
    Ghosh S; Matsuoka Y; Kitano H
    Drug Discov Today; 2010 Dec; 15(23-24):1024-31. PubMed ID: 20934535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-on drugs: how far should chemists look?
    Giordanetto F; Boström J; Tyrchan C
    Drug Discov Today; 2011 Aug; 16(15-16):722-32. PubMed ID: 21658467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 10. Forging synergies in drug discovery.
    Nat Chem Biol; 2008 Feb; 4(2):83. PubMed ID: 18202672
    [No Abstract]   [Full Text] [Related]  

  • 11. To measure is to know: an approach to CADD performance metrics.
    Loughney D; Claus BL; Johnson SR
    Drug Discov Today; 2011 Jul; 16(13-14):548-54. PubMed ID: 21605697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putting nature back into drug discovery.
    Müller-Kuhrt L
    Nat Biotechnol; 2003 Jun; 21(6):602. PubMed ID: 12776140
    [No Abstract]   [Full Text] [Related]  

  • 13. Learning lessons from drugs that have recently entered the market.
    Teague SJ
    Drug Discov Today; 2011 May; 16(9-10):398-411. PubMed ID: 21414418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A return to the fundamentals of drug discovery?
    Williams M
    Curr Opin Investig Drugs; 2004 Jan; 5(1):29-33. PubMed ID: 14983970
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.
    Vanderwall DE; Yuen N; Al-Ansari M; Bailey J; Fram D; Green DV; Pickett S; Vitulli G; Luengo JI; Almenoff JS
    Drug Discov Today; 2011 Aug; 16(15-16):646-53. PubMed ID: 21601652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous flow synthesis. A pharma perspective.
    Malet-Sanz L; Susanne F
    J Med Chem; 2012 May; 55(9):4062-98. PubMed ID: 22283413
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspectives on plasmid-based gene therapy: challenges for the product and the process.
    Kelly WJ
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):219-23. PubMed ID: 12672266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel genomic methods for drug discovery and mechanism-based toxicological assessment.
    Gant TW; Zhang SD; Taylor EL
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):72-80. PubMed ID: 19152215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strength and honor through the pharmaceutical industry's embrace of green chemistry?
    Fortunak J; Confalone PN; Grosso JA
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):651-3. PubMed ID: 17987518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.